Related references
Note: Only part of the references are listed.Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells
Ningqin Lin et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics
Yi Zhong et al.
ANALYTICAL BIOCHEMISTRY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers
David R. Bell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Nadine Reischmann et al.
ONCOGENE (2020)
Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma
Jessica Lopes-Nunes et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia
Catriona Jamieson et al.
BLOOD CANCER DISCOVERY (2020)
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity
Charles R. Schmidt et al.
BLOOD CANCER DISCOVERY (2020)
In vitro selection of DNA aptamers recognizing drug-resistant ovarian cancer by cell-SELEX
Junqing He et al.
TALANTA (2019)
Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settings
Kristy Kummerow Broman et al.
EXPERT OPINION ON DRUG SAFETY (2019)
An ssDNA aptamer selected by Cell-SELEX for the targeted imaging of poorly differentiated gastric cancer tissue
Wanming Li et al.
TALANTA (2019)
A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein
Hui Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Mutations of key driver genes in colorectal cancer progression and metastasis
Dongdong Huang et al.
CANCER AND METASTASIS REVIEWS (2018)
Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX
Wan-Ming Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Malignant Melanoma: Diagnostic and Management Update
Thomas Knackstedt et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Self-Assembled Aptamer-Grafted Hyperbranched Polymer Nanocarrier for Targeted and Photoresponsive Drug Delivery
Lu Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+melanoma stem cells
Yi-bin Zeng et al.
ACTA PHARMACOLOGICA SINICA (2018)
RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice
Nobutaka Nakamara et al.
MOLECULAR MEDICINE (2017)
Post-SELEX optimization of aptamers
Shunxiang Gao et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma
Lynette M. Sholl et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature
Muhammad Ahmed Farooq Anwar et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Amanda I. Phipps et al.
GASTROENTEROLOGY (2015)
B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Ricarda Herr et al.
CANCER RESEARCH (2015)
Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells
Wan-Ming Li et al.
BIOMATERIALS (2014)
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Grant A. McArthur et al.
LANCET ONCOLOGY (2014)
Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
Yanling Song et al.
ANALYTICAL CHEMISTRY (2013)
Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
L. Heinzerling et al.
BRITISH JOURNAL OF CANCER (2013)
Historical review of melanoma treatment and outcomes
Carrie Lee et al.
CLINICS IN DERMATOLOGY (2013)
PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imaging
Ping Gong et al.
BIOMATERIALS (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
BRAF targeted therapy changes the treatment paradigm in melanoma
Antoni Ribas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Bifunctional combined aptamer for simultaneous separation and detection of thrombin
Tao Bing et al.
BIOSENSORS & BIOELECTRONICS (2010)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Molecular recognition of acute myeloid leukemia using aptamers
K. Sefah et al.
LEUKEMIA (2009)
Share Paper
